Learn, Analyse & Invest
only with
only with
+91
Download Orca
Amerise Biosciences Ltd.
Amerise Biosciences
₹ 0.00
0.00 (0.00)%
NSE
BSE
Finance
Small-cap - With a market cap of ₹4.56 Cr.
| EX-Date | Purpose |
|---|---|
| 20 05 2021 | Audited Results |
| 10 08 2021 | Quarterly Results & Inter alia, 2.) To consider change in name of the Company from Amradeep Industries Limited as approved by Registrar of Companies and members. 3.) Change in Object Clause of the company. 4.) To approve notice of Postal Ballot General Meeting to seek approval for the above mentioned items as recommended by Board. 5.) To consider and decide book closure date and cut-off date for e-voting purpose. 6.) To appoint the Scrutinizer for the Postal Ballot Process. 7.) Any other business as Board deem fit to discuss, with the permission of the Chairman. |
| 12 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 28 05 2022 | Audited Results |
| 03 08 2022 | Quarterly Results |
| 08 08 2022 | Quarterly Results (Revised) The meeting of the Board of Directors of the Company to be held on 3rd August 2022 is postponed and rescheduled on 8th August 2022 interalia, to consider following business.- 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2022. 2.) Any other matter with the permission of the board which the Board may think fit. |
| 12 11 2022 | Quarterly Results |
| 25 01 2023 | Quarterly Results |
| 04 05 2023 | Audited Results |
| 08 08 2023 | Quarterly Results |
| 07 11 2023 | Quarterly Results |
| 22 01 2024 | Quarterly Results |
| 22 10 2024 | Quarterly Results |
| 03 02 2025 | Quarterly Results Inter alia, to consider and approve:- 1.) To approve and consider the appointment of Mr. Kelash Bunkar as Director of the Company. 2.) To consider the resignation of Mr. Niraj Vaghela from directorship of the Company. 3.) Any other matter with the permission of the board which the Board may think fit. |
| 19 05 2025 | Audited Results |
| 24 07 2025 | Quarterly Results |
| 05 11 2025 | Quarterly Results |
| 02 02 2026 | Quarterly Results |
| 05 05 2026 | Audited Results |
News
No News data available
